This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: University of Pennsylvania, The Wistar Institute, Fox Chase Cancer Center. Active years: 2016-2026.
Company Filing History:



Years Active: 2016-2026
Title: Innovations and Contributions of Inventor Donna L George
Introduction
Donna L George is a prominent inventor based in Blue Bell, PA (US). She has made significant contributions to the field of cancer research through her innovative work on HSP70 inhibitors. With a total of 3 patents, her research focuses on developing therapies for diseases related to HSP70.
Latest Patents
One of her latest patents involves small molecule HSP70 inhibitors. In this groundbreaking work, a previously unidentified hydrophobic pocket was discovered in the C-terminal domain of DnaK and human HSP70. This discovery led to the identification of a novel chemical scaffold for compounds that can treat diseases associated with this hydrophobic pocket. The compounds are designed to inhibit HSP70 or DnaK, reduce HSP70 in the mitochondria of cancer cells, and treat malignant neoplastic diseases. Additionally, these compounds have resulted in new methods for screening HSP70 or DnaK inhibitors by utilizing the three-dimensional structure of the hydrophobic pocket.
Another significant patent by Donna L George focuses on modulators of HSP70/DnaK function and methods of use. This patent discloses compositions and methods for modulating HSP70 function, particularly aimed at the targeted killing of cancer cells.
Career Highlights
Throughout her career, Donna has worked with esteemed institutions such as the University of Pennsylvania and Fox Chase Cancer Center. Her research has been pivotal in advancing the understanding of HSP70 and its implications in cancer treatment.
Collaborations
Donna has collaborated with notable colleagues, including Julia I-Ju Leu and Maureen E Murphy, contributing to the collective effort in cancer research and therapy development.
Conclusion
Donna L George's innovative work in the field of HSP70 inhibitors showcases her dedication to advancing cancer treatment. Her contributions through her patents and collaborations highlight the importance of research in developing effective therapies for challenging diseases.